Search

everythinglearnresearchcommunity

for

Search:↓

Adenosine helps hair grow longer and stronger by boosting certain growth factors and signaling pathways.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Finasteride increases CD8+ T cells in BPH tissues.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Adrenocorticotropic hormone inhibits growth and affects body composition in male rats.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

5α-reductase 2 is crucial for stress response in male rats.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The new assay can help develop products for hair re-growth.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Certain gene variations may increase the risk and severity of alopecia areata.

Astressin-B can reverse and prevent hair loss in stressed mice.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Thyroid receptor β can help develop new drugs to treat hair loss.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

MC-1R is present in skin cells and may help reduce inflammation.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

Targeting neurosteroids may help prevent drug relapse.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Testosterone needs to be converted to DHT to reduce stress response in male rats.